Maximum quantity allowed is 999
Please select the quantity
CAS RN: 112052-11-6 | Product Number: T4367
(S)-Tetrahydrofuran-3-yl 4-Methylbenzenesulfonate
×
![]()
×
New
Purity: >98.0%(HPLC)
Synonyms:
- (3S)-Tetrahydro-3-furanyl 4-Methylbenzenesulfonate
- (S)-Toluene-4-sulfonic Acid Tetrahydrofuran-3-yl Ester
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Quantity |
Shipping Information
|
|---|---|---|---|---|---|---|
| 5G |
S$184.50
|
16 | 0 | Contact Us |
|
|
| 25G |
S$586.50
|
16 | 0 | Contact Us |
|
* Please contact our distributors or
TCI
to order TCI products.
* The storage conditions are subject to change without notice.
| Product Number | T4367 |
Purity / Analysis Method 
|
>98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__1H__1__4O__4S = 242.29 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Frozen (-20°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Moisture Sensitive,Heat Sensitive |
| CAS RN | 112052-11-6 |
| Reaxys Registry Number | 4458174 |
| MDL Number | MFCD08704351 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 37.0 to 41.0 °C |
| Specific rotation | -4.0 to -6.0 deg(C=2, MeOH) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 39 °C |
GHS
Related Laws:
Transport Information:
| H.S.code* | 2932.19-000 |
Application
A Chiral Auxiliary Reagent for the Synthesis of Bioactive Compounds Containing the Chiral Tetrahydrofuran-3-yl Group
This product has been used to synthesize bioactive compounds containing the chiral tetrahydrofuran-3-yl group. Examples include G2019S, a leucine-rich repeat kinase 2 (LRRK2) inhibitor with potential utility in treating Parkinson's disease.
References
- Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate
- BI-3406, a Potent and Selective SOS1–KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition Free
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.